long-term use can cause significant adverse effects including kidney problems, hypertension, and non-melanoma skin cancers (Paul 2003
AHK-Cu has been studied particularly in hair follicle research and is sometimes used alongside GHK-Cu in research on the broader copper-peptide family
The coprimary end points were the relative change in body weight and a reduction of greater than or equal to 5% in body weight from baseline to week 68 with cagrilintide plus semaglutide compared with placebo
Unlike many regenerative peptides that originate from endocrine or immune signalling, BPC-157 emerged from gastrointestinal research before becoming widely investigated across musculoskeletal, vascular and connective tissue biology
Research into BPC-157 has accumulated over three decades, with studies examining its effects on tendons, ligaments, muscles, bones, the gastrointestinal tract, blood vessels, and even neurological tissue